---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-004251"
form_type: "8-K"
ticker: "HSDT"
cik: "0001610853"
company_name: "Solana Co"
filed_at: "2024-03-28T23:59:59+00:00"
generated_at: "2026-06-04T06:10:49.460176+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Helius Medical Q4 revenue down 52% YoY; net loss per share $1.47 vs $8.66

## Summary
- Q4 2023 revenue $134K, down from $282K in Q4 2022, due to US PTAP expiration and lower Canada sales.
- Net loss $1.0M in Q4 2023 vs $4.9M in Q4 2022; basic EPS loss $1.47 vs $8.66.
- FY2023 revenue $644K vs $787K; net loss $8.9M vs $14.1M; operating loss $12.4M vs $15.5M.
- Cash $5.2M at Dec 31, 2023; raised $1.3M in Q1 2024 ATM at avg $9.27/share, runway to Q3 2024.
- CMS assigned HCPCS codes for PoNS mouthpiece/controller effective Apr 1, 2024; targeting Medicare reimbursement by Oct 1, 2024.

## SEC filing metadata
- accession: 0001558370-24-004251
- form_type: 8-K
- ticker: HSDT
- cik: 0001610853
- company_name: Solana Co
- filed_at: 2024-03-28T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1610853/000155837024004251/0001558370-24-004251-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1610853/000155837024004251/hsdt-20240328x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-004251
- JSON: https://secwatch.observer/filing/0001558370-24-004251.json
- Plain text: https://secwatch.observer/filing/0001558370-24-004251.txt

## Key facts
- Earnings Releases
  Solana Co reported financial results for the quarter and full year ended December 31, 2023.
  - Period: the quarter and full year ended December 31, 2023
  - Result: reported results
  source text: On March 28, 2024, Helius Medical Technologies, Inc. (the “Registrant”) issued a press release announcing its financial results for the quarter and year ended December 31, 2023, as well as information regarding a conference call to discuss these financial results and the Registrant’s recent corporate highlights.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1610853/000155837024004251/0001558370-24-004251-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.